Children as young as 10 can be given fat jabs, WHO says

Source: Pixabay

The World Health Organization (WHO) has issued guidelines warning against giving obesity drugs or “fat jabs” to children under 10 years old. On October 7, 2026, the WHO released its first-ever global guidelines on managing childhood obesity. The report explicitly states that for children aged nine and younger, medical or surgical weight-loss interventions are highly dangerous. These guidelines come amid rising trend of fat jabs for rapid weight loss.

Global Context

Data from the United Nations reveals that childhood and obesity rates have quadrupled since 1990. A growth from 2% to approximately 8% has been recorded. As of 2024, about 180 million children and teens struggle with obesity worldwide. This includes an additional 35 million overweight children under the age of five. WHO has defined obesity as a chronic disease. It further notes that obesity significantly increases the risk of developing type 2 diabetes, cardiovascular complications, and mental health challenges.

To manage obesity among children, some parents have resorted to fat jabs. Data shows that while overall use of prescribed injections remains low, in recent years, prescriptions for GLP-1 receptor agonists for children have dramatically increased. A study published in the journal Pediatrics calculated a 310-fold increase in GLP-1 administration for children aged 8 to 11 between 2019 and 2026.

Moreover, since weight-loss injections are only approved for adolescents aged 12 and older, doctors have been prescribing “off-label” fat jabs to younger children. A major catalyst for increasing obesity rates among children around the globe is the shift to high-calorie ultra-processed foods. These foods are highly accessible and dense in sugar, salt, and unhealthy fats. In addition, sedentary lifestyles further exacerbate the problem.

WHO guidelines against fat jabs

The guidelines strongly recommend against pharmacotherapy, including GLP-1 receptor agonists like Wegovy or Mounjaro. Bariatric surgery and medical weight-management devices is also discouraged due to risks of stunted growth and development in children. The guidelines emphasize that weight loss interventions must be family-centered and focused on healthy nutrition and physical activity.

For adolescents aged 10 to 19 years, clinically approved weight-loss drugs can only be used in a supervised, multimodal lifestyle programme. Moreover, medical interventions at this stage require that the patient is physically and psychologically mature enough to handle long-term drug regimens. Bariatric surgery is limited to severe cases where an adolescent has a body mass index (BMI) greater than four standard deviations above the WHO growth median.

The guidelines reiterate the need for lifestyle changes and digital interventions. Nutritional support and regular physical activity are highly recommended. Moreover, interventions require active parental participation to support and encourage the child. Digital health tools such as wearable activity trackers under parental supervision are also recommended.

TAGGED:
Share This Article
Brendan Taylor serves as the Breaking News Editor at Insider Paper, leading coverage of major developing stories, global events, and fast-moving news. With more than five and a half years of experience as a television news producer, he brings a strong understanding of newsroom operations, editorial judgment, and the demands of real-time reporting.
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *